These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8261681)

  • 1. Plasma homocysteine in renal failure.
    Hultberg B; Andersson A; Sterner G
    Clin Nephrol; 1993 Oct; 40(4):230-5. PubMed ID: 8261681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between creatinine clearance and plasma homocysteine levels in predialytic chronic renal failure patients.
    Widiana IG; Suwitra K
    Acta Med Indones; 2004; 36(1):15-8. PubMed ID: 15931697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients--Italian initiative on uremic hyperhomocysteinemia (IIUH).
    Perna AF; Ingrosso D; Molino D; Galletti P; Montini G; Zacchello G; Bellantuono R; Caringella A; Fede C; Chimenz R; De Santo NG
    J Nephrol; 2003; 16(4):516-21. PubMed ID: 14696753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of hemodialysis and peritoneal dialysis on serum homocysteine and C-reactive protein levels.
    Borazan A; Aydemir S; Sert M; Yilmaz A
    Mediators Inflamm; 2004 Dec; 13(5-6):361-4. PubMed ID: 15770053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
    Migliacci R; Falcinelli F; Imperiali P; Floridi A; Nenci GG; Gresele P
    Ital Heart J; 2004 May; 5(5):371-7. PubMed ID: 15185901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine and its determinants in nondialyzed chronic kidney disease patients.
    Nerbass FB; Draibe SA; Feiten SF; Chiarello PG; Vannucchi H; Cuppari L
    J Am Diet Assoc; 2006 Feb; 106(2):267-70. PubMed ID: 16442876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxalic Acid as a uremic toxin.
    Mydlík M; Derzsiová K
    J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma sulfate concentration and hyperhomocysteinemia in hemodialysis patients.
    Brunetti M; Terracina L; Timio M; Saronio P; Capodicasa E
    J Nephrol; 2001; 14(1):27-31. PubMed ID: 11281340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine and methionine metabolism in renal failure.
    van Guldener C; Stehouwer CD
    Semin Vasc Med; 2005 May; 5(2):201-8. PubMed ID: 16047272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of radio contrast media on residual renal function in peritoneal dialysis patients--a prospective study.
    Dittrich E; Puttinger H; Schillinger M; Lang I; Stefenelli T; Hörl WH; Vychytil A
    Nephrol Dial Transplant; 2006 May; 21(5):1334-9. PubMed ID: 16046499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteinemia in hypertensive patients with renal target organ damage (mild renal dysfunction).
    Robles NR; Sanchez Munoz-Torrero JF; Garcia Gallego F; Velasco Gemio J; Escola JM
    Eur J Med Res; 2008 May; 13(5):196-9. PubMed ID: 18559300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
    Sjöberg B; Anderstam B; Suliman M; Alvestrand A
    Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis.
    Rottembourg J; Issad B; Gallego JL; Degoulet P; Aime F; Gueffaf B; Legrain M
    Proc Eur Dial Transplant Assoc; 1983; 19():397-403. PubMed ID: 6878254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The importance of homocysteinemia measurement in chronic renal failure].
    Cabarkapa V; Stosić Z; Zeravica R; Ilincić B
    Med Pregl; 2007; 60 Suppl 2():81-3. PubMed ID: 18928165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis.
    Chuang CK; Lin SP; Chen HH; Chen YC; Wang TJ; Shieh WH; Wu CJ
    Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with increased plasma homocysteine in patients using an amino acid peritoneal dialysis fluid.
    Yang SY; Huang JW; Shih KY; Hsu SP; Chu PL; Chu TS; Wu KD
    Nephrol Dial Transplant; 2005 Jan; 20(1):161-6. PubMed ID: 15572386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of tubular anion and cation secretion to residual renal function in chronic dialysis patients.
    van Olden RW; van Acker BA; Koomen GC; Krediet RT; Arisz L
    Clin Nephrol; 1998 Mar; 49(3):167-72. PubMed ID: 9543598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F; Floridi AG; Floridi A; Buoncristiani U
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF-alpha: mRNA, plasma protein levels and soluble receptors in patients on chronic hemodialysis, on CAPD and with end-stage renal failure.
    van Riemsdijk-van Overbeeke IC; Baan CC; Hesse CJ; Loonen EH; Niesters HG; Zietse R; Weimar W
    Clin Nephrol; 2000 Feb; 53(2):115-23. PubMed ID: 10711413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.